Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escalation therapy of an MS relapse by methylprednisolone vs immunoadsorption
DRKS00014289Phase 3Terminated
- Sponsor
- Universitätsklinikum Leipzig
- Start
- Jun 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone in multiple sclerosis (MS) (2 arms), sponsored by Universitätsklinikum Leipzig. Started Jun 2018; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on DRKS00014289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014289.